Related Experiment Video

Updated: Jun 2, 2026

Mouse Cardiac Arrest Model for Brain Imaging and Brain Physiology Monitoring During Ischemia and Resuscitation
07:18

Mouse Cardiac Arrest Model for Brain Imaging and Brain Physiology Monitoring During Ischemia and Resuscitation

Published on: April 14, 2023

[Cerebrocardiorenal syndrome--the new concept in geriatrics]

A L Ar'ev, N A Ovsiannikova, N M Zhulev

    Advances in Gerontology = Uspekhi Gerontologii
    |April 23, 2011
    PubMed

    Insights

    This review highlights shared risk factors for brain, heart, and kidney diseases. These interconnected conditions, termed cerebrocardiorenal syndrome, necessitate a unified approach, especially in geriatric patients.

    Area of Science:

    • Nephrology
    • Cardiology
    • Neurology
    • Geriatrics

    Background:

    • Pathology in the brain, cardiovascular system, and kidneys often share common origins.
    • Understanding these shared mechanisms is crucial for effective disease management.

    Purpose of the Study:

    • To review the risk factors contributing to the development and progression of brain, cardiovascular, and kidney diseases.
    • To explore the interconnectedness of these pathologies and propose a unified conceptual framework.

    Main Methods:

    • Comprehensive literature analysis of existing research on risk factors and pathogenetic mechanisms.
    • Comparative analysis of risk factors across cerebrovascular, cardiovascular, and chronic kidney diseases.

    Main Results:

    • Identified uniform pathogenetic mechanisms underlying the development and progression of these diseases.
    • Demonstrated that risk factors for cerebrovascular diseases are also risk factors for cardiovascular illnesses and chronic kidney disease.

    Conclusions:

    • The concept of "cerebrocardiorenal syndrome" or "cerebrocardiorenal continuum" is proposed, reflecting the interconnected nature of these conditions.
    • An interdisciplinary approach is essential for managing geriatric patients with these overlapping pathologies.

    Related Concept Videos

    Pharmacodynamics in Geriatric Patients: Effects of Age01:27

    Pharmacodynamics in Geriatric Patients: Effects of Age

    Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Cerebral Edema ll: Pathophysiology01:22

    Cerebral Edema ll: Pathophysiology

    Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

    Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

    The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

    Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

    The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...